Live Breaking News & Updates on Telix Pharma|Page 5

Stay updated with breaking news from Telix pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Telix Pharmaceuticals Limited: ProstACT Update: TARGET Study Ethics Approval

MELBOURNE, Australia, April 12, 2022 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its ProstACT TARGET Phase II clinical trial of the Company's ....

United States , Cdx Illuccix , Christian Behrenbruch , Telix Pharmaceuticals , Human Research Ethics Committee , Drug Administration , Telix Group , Australian Securities Exchange , Australian Therapeutic Goods Administration , Prnewswire Telix Pharmaceuticals Limited , Pharmaceuticals Limited , Managing Director , Care Global Chief Medical Officer , Wally Curran , Molecularly Targeted Radiation , Group Chief Executive , Telix Pharmaceuticals Limited ,

Telix Pharmaceuticals Limited: Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix

MELBOURNE, Australia and LIÈGE, Belgium, March 29, 2022 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with ....

City Of , United Kingdom , United States , Shepton Mallet , Republic Of Ireland , Jack Knight , Richard Valeix , Christian Behrenbruch , European Association Of Urology , Telix Pharmaceuticals , Drug Administration , Australian Securities Exchange , Prnewswire Telix Pharmaceuticals Limited , Xiel Ltd , Australian Therapeutic Goods Administration , Nuclear Medicine , Xiel Limited , National Comprehensive Cancer Network , Pharmaceuticals Limited , Diagnostic Radiology , Managing Director , Prostate Cancer , Molecularly Targeted Radiation , Group Chief Executive , Telix Pharmaceuticals Limited , Limited Update March ,

Telix Pharmaceuticals Limited: Telix Advances Development of Glioblastoma Therapy Program

MELBOURNE, Australia, March 23, 2022 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces it has made significant progress in advancing the Company's glioblastoma ....

United States , Colin Hayward , Josef Pichler , Christian Behrenbruch , Andrew Scott , Telix Pharmaceuticals , Kepler University Hospital In Linz Austria , Human Research Ethics Committee , Kepler University Hospital , Drug Administration , Australian Securities Exchange , Australian Therapeutic Goods Administration , Prnewswire Telix Pharmaceuticals Limited , Pharmaceuticals Limited , Hui Gan , Olivia Newton John Cancer Research Institute , Austin Health , Principal Investigators , Chief Medical Officer , Principal Investigator , Molecularly Targeted Radiation , Managing Director , Group Chief Executive , Telix Pharmaceuticals Limited ,

EAU Updates Guidance for PSMA-PET Imaging

Telix welcomes EAU Guidelines recognise PSMA PET/CT as more accurate than CT and bone scan for the staging of high-risk prostate cancer, based on clinical data. ....

Privacy Policy , Eau Guidelines , Sma Pet Ct , T And Bone Scan , Prostate Cancer , Clinical Data , Ealth Press Release ,

Telix Pharmaceuticals Limited: EAU Updates Guidance for PSMA-PET Imaging

MELBOURNE, Australia and LIÈGE, Belgium, March 21, 2022 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) welcomes the updated 2022 'Guidelines on Prostate Cancer' (the Guidelines) ....

Kyahn Williamson , Colin Hayward , Stefano Fanti , Christian Behrenbruch , European Association Of Urology , Telix Pharmaceuticals , Drug Administration , Australian Therapeutic Goods Administration , Nuclear Medicine , Corporate Communications , Telix Pharmaceuticals Limited , University Of Bologna , Pharmaceuticals Limited , Prostate Cancer , European Association , Telix Chief Medical Officer , European Marketing Authorisation Approvals , Molecularly Targeted Radiationand , Managing Director , Group Chief Executive , Limited Update March ,